Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.
Scholarly article — Journal Article / Research Support, N.I.H., Extramural / Research Support, Non-U.S. Gov't / research-article
Study designOther literature / records
SubjectHuman & animal
Record checks
- Study design
- Other literature / records
- Subject
- Human & animal
- Publication year
- 2019
- Source
- doi.org
- Abstract display
- Not reproduced here
- Publication status
- Active
- Status checked
- 17 Aug 2026
- Collected
- 13 Aug 2026
- Freshness
- Current
- Review stage
- Automated
- Record status
- Published
Abstract
The abstract is not reproduced here. Please consult the original source.
MeSH
DOI 10.1158/1535-7163.mct-18-0708
PMID 31395686
View source →